---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-280142"
form_type: "8-K"
ticker: "AKBA"
cik: "0001517022"
company_name: "Akebia Therapeutics, Inc."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T03:30:32.773846+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Akebia Therapeutics cuts 14% of commercial workforce, expects $1.8M restructuring charge

## Summary
- Board approved reducing commercial organization by ~14% (~1.8M charge) due to shift to strategic account model.
- Restructuring charge of ~$1.8M in Q4 2022 for severance, benefits, and stock-based compensation.
- Reduction driven by Auryxia maturity, COVID-19 impact on dialysis centers, and potential limited vadadustat focus.
- Workforce reduction expected to be substantially completed by end of Q4 2022.
- Company aims to lower operating costs and fund operations with existing cash and cash from operations.

## SEC filing metadata
- accession: 0001193125-22-280142
- form_type: 8-K
- ticker: AKBA
- cik: 0001517022
- company_name: Akebia Therapeutics, Inc.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517022/000119312522280142/0001193125-22-280142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517022/000119312522280142/d76469d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-280142
- JSON: https://secwatch.observer/filing/0001193125-22-280142.json
- Plain text: https://secwatch.observer/filing/0001193125-22-280142.txt

## Key facts
- Restructurings & Charges
  Akebia Therapeutics, Inc. announced a restructuring with charges of approximately $1.8 million affecting commercial organization (approximately 14%).
  - Type: restructuring
  - Charge: approximately $1.8 million
  - Affected area: commercial organization
  - Headcount: approximately 14%
  source text: be offered separation benefits, including severance payments, healthcare coverage and related benefits. The Company expects to record a restructuring charge of approximately $1.8 million primarily related to one-time and contractual termination benefits including severance, non-cash stock-based compensation expense, healthcare and related benefits in the fourth
  evidence_url: https://www.sec.gov/Archives/edgar/data/1517022/000119312522280142/0001193125-22-280142-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.